Drugplain

Benzonatate 200 mg/1

Benzonatate · CAPSULE · RedPharm Drug, Inc.

7 Recalls on Record
Plain English

Benzonatate is a capsule containing benzonatate at 200 mg/1, taken oral. Manufactured by RedPharm Drug, Inc..

Key Facts

Brand Name
Benzonatate
Generic Name
Benzonatate
NDC Code (Product)
67296-1751
Manufacturer
RedPharm Drug, Inc.
Strength
200 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
ANDA206948
Drug Class
Non-narcotic Antitussive [EPC]
Marketing Start
01/01/2020

Recall History

7 Recalls on Record
Class II11/26/2014

Zydus Pharmaceuticals USA Inc

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

TerminatedVoluntary: Firm initiated
Class I01/15/2021

Calvin Scott & Company, Inc.

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

TerminatedVoluntary: Firm initiated
Class III05/09/2017

Strides Pharma INC

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

TerminatedVoluntary: Firm initiated
Class III09/24/2014

Zydus Pharmaceuticals USA Inc

Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

TerminatedVoluntary: Firm initiated
Class III12/26/2023

Amerisource Health Services LLC

Superpotent drug: Assay results were slightly above specification at the time zero point.

OngoingVoluntary: Firm initiated
Class II01/06/2015

American Health Packaging

Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules

TerminatedVoluntary: Firm initiated
Class II12/23/2014

Zydus Pharmaceuticals USA Inc

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

chronic kidney disease1,233 reports
fatigue1,218 reports
cough1,184 reports
dyspnoea1,138 reports
pneumonia1,099 reports
diarrhoea1,079 reports
nausea1,058 reports
pain918 reports
renal failure871 reports
death829 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Benzonatate Capsule is indicated for the symptomatic relief of cough.

Dosage & Administration

DOSAGE AND ADMINISTRATION Adults and Children over 10 years of age Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. Benzonatate Capsules should be swallowed whole. Benzonatate Capsules are not to be broken, chewed, dissolved, cut or crushed.

Warnings

WARNINGS Hypersensitivity Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures. Psychiatric Effects Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking Benzonatate Capsule in combination with other prescribed drugs. Accidental Ingestion and Death in Children Keep Benzonatate Capsules out of reach of children. Accidental ingestion of Benzonatate Capsules resulting in death has been reported in children below age 10. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. If accidental ingestion occurs, seek medical attention immediately (see OVERDOSAGE ).

Contraindications

CONTRAINDICATIONS Hypersensitivity to benzonatate or related compounds.

Adverse Reactions

ADVERSE REACTIONS Potential Adverse Reactions to Benzonatate Capsules may include: Hypersensitivity reactions including bronchospasm, laryngospasm,cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule. CNS: sedation; headache; dizziness; mental confusion; visual hallucinations. GI: constipation; nausea; GI upset. Dermatologic: pruritus; skin eruptions. Other: nasal congestion; sensation of burning in the eyes; vague "chilly" sensation; numbness of the chest; hypersensitivity. Deliberate or accidental overdose has resulted in death, particularly in children.

Frequently Asked Questions

What is Benzonatate used for?

Benzonatate contains Benzonatate. It is a capsule taken oral. Consult your doctor for specific uses.

Is Benzonatate a controlled substance?

Benzonatate is not classified as a controlled substance by the DEA.

What is the generic name for Benzonatate?

The generic name for Benzonatate is Benzonatate. There are 1 other brand versions of Benzonatate.

What is the NDC code for Benzonatate 200 mg/1?

The NDC (National Drug Code) for Benzonatate 200 mg/1 is 67296-1751, listed by RedPharm Drug, Inc..